Blood clot treatments subject of major trial
School of Medicine researchers will lead a $10 million multicenter clinical trial of an aggressive treatment for blood clots in the leg known as deep vein thrombosis.
Worm genome offers clues to evolution of parasitism
The genome of a humble worm that dines on the microbial organisms covering the carcasses of dead beetles may provide clues to the evolution of parasitic worms, including those that infect humans, say scientists at the School of Medicine and the Max-Planck Institute for Developmental Biology in Germany. In a paper published in the current issue of Nature Genetics, the researchers reported finding some surprises as they have decoded the genome of the worm, a tiny nematode called Pristionchus pacificus.
New predictive tool can help determine treatment of breast cancer patients
A new predictive measurement, called a PEPI score, could bring good news to many women diagnosed with advanced breast cancer — a low PEPI (preoperative endocrine prognostic index) score could show that they have little risk of relapse and can safely avoid chemotherapy after surgery. For others, a high PEPI score could warn that the risk of relapse after breast surgery is large and indicate that careful follow-up and aggressive therapy may be needed, say researchers at the School of Medicine.
Racial disparities decline for cancer in Missouri
Cancer death rates in the United States are highest among African Americans, but a new report shows that in Missouri the disparity in cancer incidence and death between African Americans and whites is declining. As a result, cancer incidence (the rate of newly diagnosed cases) between the races is equal, although the death rate will probably remain higher for African Americans for some time.
Assessing cardiovascular risk for HIV patients
WUSTL researchers and colleagues reported that the risk for heart attack is 70 percent to 80 percent higher among people with HIV compared to those who do not have HIV.
Zoberi named medical director of radiation oncology at Siteman’s West County facility
Imran Zoberi has been named medical director of radiation oncology at the Siteman Cancer Center at Barnes-Jewish West County Hospital in Creve Coeur, Mo. Zoberi is assistant professor of radiation oncology at the School of Medicine. As medical director, Zoberi will manage medical support staff and oversee patient care in radiation oncology.
Assessing cardiovascular risk for HIV patients
WUSTL researchers and colleagues reported that the risk for heart attack is 70 percent to 80 percent higher among people with HIV compared to those who do not have HIV.
Stem cells may boost heart disease treatment
Mouse embryonic stem cells can work to build the heart, potentially moving medical science a step closer to new heart-disease treatments that use human stem cells, School of Medicine research shows.
A healing mission
Courtesy PhotoJosh VanRiper, president of the Program in Physical Therapy’s Class of 2010, performs physical therapy on a young boy during a recent trip to the Dominican Republic by six students in the Program in Physical Therapy.
KL2 Career Development Award applications due Sept. 30
Applications for KL2 Career Development Award scholars to begin July 2009 are being accepted through Sept. 30 at 5 p.m.
View More Stories